Showing results (91-100 of 215) with videos related to
Sort By:
Pageof 22
Neuropharmacology|December 10, 1999
Functional characterization and expression of thalamic GABA(B) receptors in a rodent model of Parkinson's diseaseC de Groote, U Wüllner, P A Löchmann, et al.European Neurology|July 17, 2001
Executive dysfunction in spinocerebellar ataxia type 1K Bürk, S Bösch, C Globas, et al.Neurology|April 4, 2000
Neurologic complications in immune-mediated heparin-induced thrombocytopeniaC Pohl, U Harbrecht, A Greinacher, et al.Journal of Neurology|April 14, 2005
Sensorineural hearing loss in patients with chronic progressive external ophthalmoplegia or Kearns-Sayre syndromeC Kornblum, R Broicher, E Walther, et al.Journal of Neurology|February 8, 2003
Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3K Bürk, C Globas, S Bösch, et al.Experimental Brain Research|January 1, 1986
GABAergic neurotransmission within the reticular part of the substantia nigra (SNR): role for switching motor patterns and performance of movementsC Heim, M Schwarz, T Klockgether, et al.Neuroscience Letters|March 7, 1997
The NMDA antagonist memantine impairs classical eyeblink conditioning in humansM M Schugens, R Egerter, I Daum, et al.Journal of Neurology|January 13, 2000
MRI findings in Hirayama's disease: flexion-induced cervical myelopathy or intrinsic motor neuron disease?R Schröder, E Keller, S Flacke, et al.Clinical Neuropharmacology|April 15, 1999
Tremorlytic activity of budipine in Parkinson's diseaseS Spieker, R Eisebitt, S Breit, et al.European Journal of Pharmacology|April 22, 1996
Effects of the antiparkinsonian drug budipine on central neurotransmitter systemsT Klockgether, U Wüllner, J P Steinbach, et al.Pageof 22